24/03/2022 | Booklet

Reflections on Life Sciences Predictions for 2022 | Thriving in the post-COVID Pharma, Medtech and Digital Health Market

 
 
 
Share
 

A report by Roberto AscioneGerry Chillé, Fulvio Fortini, Petteri Kolhemainen, Kristin Milburn, Francis NamoukAriel Salmang and Paul Tunnah

Catalysed by the pandemic, the momentum of the technological evolution in the life sciences industry has accelerated to become a veritable revolution.

When Healthware was founded in 1997, digital barely had a mention in the analogue world of traditional medicine. By 2017, the FDA had launched its Digital Unit, and here we are now in 2022, at the true convergence of medicine and digital. It has finally arrived, bringing with it an opportunity that is critical for companies to embrace.

In January, we shared our ten predictions for 2022 in a webinar, along with key considerations for each. Here, we succinctly summarise these predictions, along with clear recommendations on how to act on the opportunity they present.

 

Request the free report

 

  • Artificial Intelligence
  • Behavior Change
  • Big Data
  • Clinical Trials
  • Communication
  • Digital health
  • Digital health revolution
  • Digital Health Transformation
  • Digital Pharma
  • Digital Strategy
  • Digital Therapies
  • Empathy
  • HCP
  • Innovation
  • LEADERSHIP
  • PHARMA INDUSTRY
  • Purpose
  • Responsibility
  • Scale
  • Spirit
  • Technology
  • TELEHEALTH